{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:57:03Z","timestamp":1791946623845,"version":"4.3.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007547","name":"Fourth Military Medical University","doi-asserted-by":"publisher","award":["2022ZZXM044"],"award-info":[{"award-number":["2022ZZXM044"]}],"id":[{"id":"10.13039\/501100007547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007547","name":"Fourth Military Medical University","doi-asserted-by":"publisher","award":["2020SWAQ09"],"award-info":[{"award-number":["2020SWAQ09"]}],"id":[{"id":"10.13039\/501100007547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007547","name":"Fourth Military Medical University","doi-asserted-by":"publisher","award":["2018JSTS03"],"award-info":[{"award-number":["2018JSTS03"]}],"id":[{"id":"10.13039\/501100007547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002132"],"award-info":[{"award-number":["82002132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072268"],"award-info":[{"award-number":["82072268"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017592","name":"Key Science and Technology Program of Shaanxi Province","doi-asserted-by":"publisher","award":["2014A7"],"award-info":[{"award-number":["2014A7"]}],"id":[{"id":"10.13039\/501100017592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2019ZDLSF02-04"],"award-info":[{"award-number":["2019ZDLSF02-04"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-024-02613-6","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T06:44:31Z","timestamp":1738997071000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Standardization, validation, and comparative evaluation of a convenient surrogate recombinant vesicular stomatitis virus plaque reduction test for quantification of Hantaan orthohantavirus (HTNV) neutralizing antibodies"],"prefix":"10.1186","volume":"22","author":[{"given":"Jing","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfeng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangchao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfeng","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinlan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengbo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanglin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,8]]},"reference":[{"issue":"9","key":"2613_CR1","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1016\/S1473-3099(23)00128-7","volume":"23","author":"PA Vial","year":"2023","unstructured":"Vial PA, Ferr\u00e9s M, Vial C, Klingstr\u00f6m J, Ahlm C, L\u00f3pez R, Le Corre N, Mertz GJ. Hantavirus in humans: a review of clinical aspects and management. Lancet Infect Dis. 2023;23(9):e371\u201382. https:\/\/doi.org\/10.1016\/S1473-3099(23)00128-7.","journal-title":"Lancet Infect Dis"},{"key":"2613_CR2","first-page":"28","volume":"1989","author":"WP Guo","year":"1989","unstructured":"Guo WP, Xu HF, Wang JY, Bai XF, Yang WS, Sun ZC. High valent immunoglobulin used for the treatment of epidemic hemorrhagic fever. People\u2019s Military Medical. 1989;1989:28.","journal-title":"People\u2019s Military Medical"},{"key":"2613_CR3","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S0006-291X(02)02491-9","volume":"298","author":"Z Xu","year":"2002","unstructured":"Xu Z, Wei L, Wang L, Wang H, Jiang S. The in vitro and in vivo protective activity of monoclonal antibodies directed against Hantaan virus: potential application for immunotherapy and passive immunization. Biochem Biophys Res Commun. 2002;298:552\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"2613_CR4","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.1128\/AAC.00728-09","volume":"53","author":"R Xu","year":"2009","unstructured":"Xu R, Yang XY, Yang DF, Zou CY, Gong PL, Zeng FD. Phase I evaluation of the safety and pharmacokinetics of a single-dose intravenous injection of a murine monoclonal antibody against Hantaan virus in healthy volunteers. Antimicrob Agents Chemother. 2009;53:5055\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"2613_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3851\/IMP2875","volume":"20","author":"PA Vial","year":"2015","unstructured":"Vial PA, Valdivieso F, Calvo M, Rioseco ML, Riquelme R, Araneda A, Tomicic V, Graf J, Paredes L, Florenzano M, et al. A non-randomized multicentre trial of human immune plasma for treatment of hantavirus cardiopulmonary syndrome caused by Andes virus. Antivir Ther. 2015;20:377\u201386.","journal-title":"Antivir Ther"},{"key":"2613_CR6","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.vaccine.2016.01.031","volume":"34","author":"JY Song","year":"2016","unstructured":"Song JY, Woo HJ, Cheong HJ, Noh JY, Baek LJ, Kim WJ. Long-term immunogenicity and safety of inactivated Hantaan virus vaccine (Hantavax\u2122) in healthy adults. Vaccine. 2016;34:1289\u201395.","journal-title":"Vaccine"},{"key":"2613_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/23744235.2017.1353704","volume":"50","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Zhou BY, Wei J, Xu Y, Dong JH, Guan LY, Ma P, Yu PB, Wang JJ. Persistence of immune responses to vaccine against haemorrhagic fever with renal syndrome in healthy adults aged 16\u201360 years: results from an open-label2-year follow-up study. Infect Dis (Lond). 2018;50:21\u20136.","journal-title":"Infect Dis (Lond)"},{"key":"2613_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01203","author":"C Ye","year":"2019","unstructured":"Ye C, Wang D, Liu H, Ma H, Dong Y, Yao M, Wang Y, Zhang H, Zhang L, Cheng L, et al. An improved enzyme-linked focus formation assay revealed baloxavir acid as a potential antiviral therapeutic against hantavirus infection. Front Pharmacol. 2019. https:\/\/doi.org\/10.3389\/fphar.2019.01203.","journal-title":"Front Pharmacol"},{"key":"2613_CR9","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1128\/jcm.20.6.1213-1215.1984","volume":"20","author":"O Tanishita","year":"1984","unstructured":"Tanishita O, Takahashi Y, Okuno Y, Yamanishi K, Takahashi M. Evaluation of focus reduction neutralization test with peroxidase-antiperoxidase staining technique for hemorrhagic fever with renal syndrome virus. J Clin Microbiol. 1984;20:1213\u20135.","journal-title":"J Clin Microbiol"},{"key":"2613_CR10","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3389\/fcimb.2020.00444","volume":"10","author":"C Vial","year":"2020","unstructured":"Vial C, Whitaker A, Wilhelm J, Ovalle J, Perez R, Valdivieso F, Ferres M, Martinez-Valdebenito C, Eisenhauer P, Mertz GJ, et al. Comparison of VSV Pseudovirus and Focus Reduction Neutralization Assays for Measurement of Anti-Andes orthohantavirus Neutralizing Antibodies in Patient Samples. Front Cell Infect Microbiol. 2020;10:444.","journal-title":"Front Cell Infect Microbiol"},{"key":"2613_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41541-024-00814-2","volume":"9","author":"H Zhang","year":"2024","unstructured":"Zhang H, Liu H, Wei J, Dang Y, Wang Y, Yang Q, Zhang L, Ye C, Wang B, Jin X, et al. Single dose recombinant VSV based vaccine elicits robust and durable neutralizing antibody against Hantaan virus. NPJ Vaccines. 2024;9:28.","journal-title":"NPJ Vaccines"},{"key":"2613_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0166-0934(89)90133-X","volume":"23","author":"J Groen","year":"1989","unstructured":"Groen J, van der Groen G, Hoofd G, Osterhaus A. Comparison of immunofluorescence and enzyme-linked immunosorbent assays for the serology of Hantaan virus infections. J Virol Methods. 1989;23:195\u2013203.","journal-title":"J Virol Methods"},{"key":"2613_CR13","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3010082","author":"JW Hooper","year":"2014","unstructured":"Hooper JW, Brocato RL, Kwilas SA, Hammerbeck CD, Josleyn MD, Royals M, Ballantyne J, Hua W, Jiao JA, Matsushita H, Sullivan EJ. DNA vaccine\u2013derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome. Sci Transl Med. 2014. https:\/\/doi.org\/10.1126\/scitranslmed.3010082.","journal-title":"Sci Transl Med"},{"key":"2613_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s007050050269","volume":"143","author":"M Kikuchi","year":"1998","unstructured":"Kikuchi M, Yoshimatsu K, Arikawa J, Yoshida R, Yoo YC, Isegawa Y, Yamanishi K, Tono-oka S, Azuma I. Characterization of neutralizing monoclonal antibody escape mutants of Hantaan virus 76118. Arch Virol. 1998;143:73\u201383.","journal-title":"Arch Virol"},{"key":"2613_CR15","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/(SICI)1096-9071(200004)60:4<446::AID-JMV13>3.0.CO;2-V","volume":"60","author":"NC de Carvalho","year":"2000","unstructured":"de Carvalho NC, Lundkvist A, Sj\u00f6lander KB, Plyusnin A, Salonen EM, Bj\u00f6rling E. A neutralizing recombinant human antibody Fab fragment against Puumala hantavirus. J Med Virol. 2000;60:446\u201354.","journal-title":"J Med Virol"},{"issue":"2","key":"2613_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.00028-20","volume":"11","author":"J Duehr","year":"2020","unstructured":"Duehr J, McMahon M, Williamson B, Amanat F, Durbin A, Hawman DW, Noack D, Uhl S, Tan GS, Feldmann H, Krammer F. Neutralizing monoclonal antibodies against the Gn and the Gc of the andes virus glycoprotein spike complex protect from virus challenge in a preclinical hamster model. mBio. 2020;11(2):10\u20131128.","journal-title":"mBio"},{"key":"2613_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109086","volume":"35","author":"TB Engdahl","year":"2021","unstructured":"Engdahl TB, Kuzmina NA, Ronk AJ, Mire CE, Hyde MA, Kose N, Josleyn MD, Sutton RE, Mehta A, Wolters RM, et al. Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection. Cell Rep. 2021;35: 109086.","journal-title":"Cell Rep"},{"key":"2613_CR18","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.3201\/eid2710.210735","volume":"27","author":"BN Williamson","year":"2021","unstructured":"Williamson BN, Prescott J, Garrido JL, Alvarez RA, Feldmann H, Barr\u00eda MI. Therapeutic efficacy of human monoclonal antibodies against andes virus infection in syrian hamsters. Emerg Infect Dis. 2021;27:2707\u201310.","journal-title":"Emerg Infect Dis"},{"key":"2613_CR19","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02531-20","author":"I Rissanen","year":"2021","unstructured":"Rissanen I, Krumm SA, Stass R, Whitaker A, Voss JE, Bruce EA, Rothenberger S, Kunz S, Burton DR, Huiskonen JT, et al. Structural basis for a neutralizing antibody response elicited by a recombinant hantaan Virus Gn immunogen. mBio. 2021. https:\/\/doi.org\/10.1128\/mBio.02531-20.","journal-title":"mBio"},{"key":"2613_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abl5399","author":"E Mittler","year":"2022","unstructured":"Mittler E, Wec AZ, Tynell J, Guardado-Calvo P, Wigren-Bystr\u00f6m J, Polanco LC, O\u2019Brien CM, Slough MM, Abelson DM, Serris A, et al. Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses. Sci Transl Med. 2022. https:\/\/doi.org\/10.1126\/scitranslmed.abl5399.","journal-title":"Sci Transl Med"},{"key":"2613_CR21","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.81743","author":"TB Engdahl","year":"2023","unstructured":"Engdahl TB, Binshtein E, Brocato RL, Kuzmina NA, Principe LM, Kwilas SA, Kim RK, Chapman NS, Porter MS, Guardado-Calvo P, et al. Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodies. Elife. 2023. https:\/\/doi.org\/10.7554\/eLife.81743.","journal-title":"Elife"},{"key":"2613_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg1855","author":"E Mittler","year":"2023","unstructured":"Mittler E, Serris A, Esterman ES, Florez C, Polanco LC, O\u2019Brien CM, Slough MM, Tynell J, Gr\u00f6ning R, Sun Y, et al. Structural and mechanistic basis of neutralization by a pan-hantavirus protective antibody. Sci Transl Med. 2023. https:\/\/doi.org\/10.1126\/scitranslmed.adg1855.","journal-title":"Sci Transl Med"},{"key":"2613_CR23","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/s41564-023-01413-y","volume":"8","author":"R Stass","year":"2023","unstructured":"Stass R, Engdahl TB, Chapman NS, Wolters RM, Handal LS, Diaz SM, Crowe JE Jr, Bowden TA. Mechanistic basis for potent neutralization of Sin Nombre hantavirus by a human monoclonal antibody. Nat Microbiol. 2023;8:1293\u2013303.","journal-title":"Nat Microbiol"},{"key":"2613_CR24","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3109\/23744235.2015.1121289","volume":"48","author":"Y Zheng","year":"2016","unstructured":"Zheng Y, Wei J, Zhou BY, Xu Y, Dong JH, Guan LY, Ma P, Yu PB, Wang JJ. Long-term persistence of anti-hantavirus antibodies in sera of patients undergoing hemorrhagic fever with renal syndrome and subjects vaccinated against the disease. Infect Dis (Lond). 2016;48:262\u20136.","journal-title":"Infect Dis (Lond)"},{"key":"2613_CR25","doi-asserted-by":"publisher","first-page":"8016","DOI":"10.1016\/j.vaccine.2020.10.035","volume":"38","author":"JY Song","year":"2020","unstructured":"Song JY, Jeong HW, Yun JW, Lee J, Woo HJ, Bae JY, Park MS, Choi WS, Park DW, Noh JY, et al. Immunogenicity and safety of a modified three-dose priming and booster schedule for the Hantaan virus vaccine (Hantavax): A multi-center phase III clinical trial in healthy adults. Vaccine. 2020;38:8016\u201323.","journal-title":"Vaccine"},{"key":"2613_CR26","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0140-6736(82)91812-8","volume":"1","author":"JB McCormick","year":"1982","unstructured":"McCormick JB, Sasso DR, Palmer EL, Kiley MP. Morphological identification of the agent of Korean haemorrhagic fever (Hantaan virus) as a member of the Bunyaviridae. Lancet. 1982;1:765\u20138.","journal-title":"Lancet"},{"key":"2613_CR27","first-page":"197","volume":"84","author":"A Takenaka","year":"1985","unstructured":"Takenaka A, Gibbs CJ, Gajdusek DC. Antiviral neutralizing antibody to Hantaan virus as determined by plaque reduction technique. Adv Virol. 1985;84:197\u2013206.","journal-title":"Adv Virol"},{"key":"2613_CR28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1006\/viro.2001.1133","volume":"289","author":"JW Hooper","year":"2001","unstructured":"Hooper JW, Larsen T, Custer DM, Schmaljohn CS. A lethal disease model for hantavirus pulmonary syndrome. Virology. 2001;289:6\u201314.","journal-title":"Virology"},{"key":"2613_CR29","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1128\/jcm.22.6.940-944.1985","volume":"22","author":"PW Lee","year":"1985","unstructured":"Lee PW, Gibbs CJ Jr, Gajdusek DC, Yanagihara R. Serotypic classification of hantaviruses by indirect immunofluorescent antibody and plaque reduction neutralization tests. J Clin Microbiol. 1985;22:940\u20134.","journal-title":"J Clin Microbiol"},{"key":"2613_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fcimb.2017.00269","volume":"7","author":"H Ma","year":"2017","unstructured":"Ma H, Ye W, Chen H, Nie T, Cheng L, Zhang L, Han P, Wu X, Xu Z, Lei Y, Zhang F. In-Cell Western Assays to Evaluate Hantaan Virus Replication as a Novel Approach to Screen Antiviral Molecules and Detect Neutralizing Antibody Titers. Front Cell Infect Microbiol. 2017;7:269.","journal-title":"Front Cell Infect Microbiol"},{"key":"2613_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jviromet.2013.06.022","volume":"193","author":"GP Barriga","year":"2013","unstructured":"Barriga GP, Martinez-Valdebenito C, Galeno H, Ferres M, Lozach PY, Tischler ND. A rapid method for infectivity titration of Andes hantavirus using flow cytometry. J Virol Methods. 2013;193:291\u20134.","journal-title":"J Virol Methods"},{"issue":"2","key":"2613_CR32","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/v16020269","volume":"16","author":"L Menke","year":"2024","unstructured":"Menke L, Sieben C. An improved workflow for the quantification of orthohantavirus infection using automated imaging and flow cytometry. Viruses. 2024;16(2):269.","journal-title":"Viruses"},{"key":"2613_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jviromet.2004.10.004","volume":"124","author":"M Aitichou","year":"2005","unstructured":"Aitichou M, Saleh SS, McElroy AK, Schmaljohn C, Ibrahim MS. Identification of dobrava, hantaan, seoul, and puumala viruses by one-step real-time RT-PCR. J Virol Methods. 2005;124:21\u20136.","journal-title":"J Virol Methods"},{"key":"2613_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081525","volume":"8","author":"W Jiang","year":"2013","unstructured":"Jiang W, Yu HT, Zhao K, Zhang Y, Du H, Wang PZ, Bai XF. Quantification of Hantaan virus with a SYBR green I-based one-step qRT-PCR assay. PLoS ONE. 2013;8: e81525.","journal-title":"PLoS ONE"},{"key":"2613_CR35","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/1743-422X-10-301","volume":"10","author":"L Yu","year":"2013","unstructured":"Yu L, Bai W, Wu X, Zhang L, Zhang L, Li P, Wang F, Liu Z, Zhang F, Xu Z. A recombinant pseudotyped lentivirus expressing the envelope glycoprotein of hantaan virus induced protective immunity in mice. Virol J. 2013;10:301.","journal-title":"Virol J"},{"key":"2613_CR36","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jviromet.2009.11.004","volume":"163","author":"N Ray","year":"2010","unstructured":"Ray N, Whidby J, Stewart S, Hooper JW, Bertolotti-Ciarlet A. Study of Andes virus entry and neutralization using a pseudovirion system. J Virol Methods. 2010;163:416\u201323.","journal-title":"J Virol Methods"},{"key":"2613_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2023.113568","volume":"522","author":"M Sim\u00f5es","year":"2023","unstructured":"Sim\u00f5es M, da Silva SA, L\u00facio KA, de Oliveira VR, Schwarcz WD, de Lima SMB, Camacho LAB. Standardization, validation, and comparative evaluation of a faster and high-performance test for quantification of yellow fever neutralizing antibodies. J Immunol Methods. 2023;522: 113568.","journal-title":"J Immunol Methods"},{"key":"2613_CR38","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.virol.2011.08.012","volume":"423","author":"MM Higa","year":"2012","unstructured":"Higa MM, Petersen J, Hooper J, Doms RW. Efficient production of Hantaan and Puumala pseudovirions for viral tropism and neutralization studies. Virology. 2012;423:134\u201342.","journal-title":"Virology"},{"key":"2613_CR39","doi-asserted-by":"publisher","first-page":"12781","DOI":"10.1128\/JVI.00794-11","volume":"85","author":"KS Brown","year":"2011","unstructured":"Brown KS, Safronetz D, Marzi A, Ebihara H, Feldmann H. Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus. J Virol. 2011;85:12781\u201391.","journal-title":"J Virol"},{"key":"2613_CR40","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3390\/v6020516","volume":"6","author":"J Prescott","year":"2014","unstructured":"Prescott J, DeBuysscher B, Brown K, Feldmann H. Long-term single-dose efficacy of a vesicular stomatitis virus-based andes virus vaccine in syrian hamsters. Viruses. 2014;6:516.","journal-title":"Viruses"},{"key":"2613_CR41","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41586-018-0702-1","volume":"563","author":"RK Jangra","year":"2018","unstructured":"Jangra RK, Herbert AS, Li R, Jae LT, Kleinfelter LM, Slough MM, Barker SL, Guardado-Calvo P, Rom\u00e1n-Sosa G, Dieterle ME, et al. Protocadherin-1 is essential for cell entry by new world hantaviruses. Nature. 2018;563:559\u201363.","journal-title":"Nature"},{"key":"2613_CR42","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s12250-020-00237-y","volume":"36","author":"T Ning","year":"2021","unstructured":"Ning T, Wang L, Liu S, Ma J, Nie J, Huang W, Li X, Li Y, Wang Y. Monitoring neutralization property change of evolving hantaan and seoul viruses with a novel pseudovirus-based assay. Virol Sin. 2021;36:104\u201312.","journal-title":"Virol Sin"},{"key":"2613_CR43","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.virs.2022.04.015","volume":"37","author":"X Wen","year":"2022","unstructured":"Wen X, Zhang L, Liu Q, Xiao X, Huang W, Wang Y. Screening and identification of HTNV(pv) entry inhibitors with high-throughput pseudovirus-based chemiluminescence. Virol Sin. 2022;37:531\u20137.","journal-title":"Virol Sin"},{"key":"2613_CR44","doi-asserted-by":"publisher","first-page":"e69708","DOI":"10.7554\/eLife.69708","volume":"10","author":"ME Dieterle","year":"2021","unstructured":"Dieterle ME, Sol\u00e0-Riera C, Ye C, Goodfellow SM, Mittler E, Kasikci E, Bradfute SB, Klingstr\u00f6m J, Jangra RK, Chandran K. Genetic depletion studies inform receptor usage by virulent hantaviruses in human endothelial cells. Elife. 2021;10:e69708.","journal-title":"Elife"},{"key":"2613_CR45","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fcimb.2020.00333","volume":"10","author":"BM Warner","year":"2020","unstructured":"Warner BM, Jangra RK, Griffin BD, Stein DR, Kobasa D, Chandran K, Kobinger GP, Safronetz D. Oral vaccination with recombinant vesicular stomatitis virus expressing sin nombre virus glycoprotein prevents sin nombre virus transmission in deer mice. Front Cell Infect Microbiol. 2020;10:333.","journal-title":"Front Cell Infect Microbiol"},{"key":"2613_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.940178","volume":"13","author":"B Wang","year":"2022","unstructured":"Wang B, Pei J, Zhang H, Li J, Dang Y, Liu H, Wang Y, Zhang L, Qi L, Yang Y, et al. Dihydropyridine-derived calcium channel blocker as a promising anti-hantavirus entry inhibitor. Front Pharmacol. 2022;13: 940178.","journal-title":"Front Pharmacol"},{"key":"2613_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.881083","volume":"12","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Zhao N, Cai Y, Zhang H, Li J, Liu J, Ye C, Wang Y, Dang Y, Li W, et al. An algal lectin griffithsin inhibits Hantaan virus infection in vitro and in vivo. Front Cell Infect Microbiol. 2022;12: 881083.","journal-title":"Front Cell Infect Microbiol"},{"key":"2613_CR48","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1083\/jcb.105.5.1957","volume":"105","author":"RW Doms","year":"1987","unstructured":"Doms RW, Keller DS, Helenius A, Balch WE. Role for adenosine triphosphate in regulating the assembly and transport of vesicular stomatitis virus G protein trimers. J Cell Biol. 1987;105:1957\u201369.","journal-title":"J Cell Biol"},{"key":"2613_CR49","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1128\/JVI.01847-10","volume":"85","author":"AJ Battisti","year":"2011","unstructured":"Battisti AJ, Chu YK, Chipman PR, Kaufmann B, Jonsson CB, Rossmann MG. Structural studies of Hantaan virus. J Virol. 2011;85:835\u201341.","journal-title":"J Virol"},{"issue":"9","key":"2613_CR50","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3390\/v11090862","volume":"11","author":"A Parvate","year":"2019","unstructured":"Parvate A, Williams EP, Taylor MK, Chu YK, Lanman J, Saphire EO, Jonsson CB. Diverse Morphology and Structural Features of Old and New World Hantaviruses. Viruses. 2019;11(9):862.","journal-title":"Viruses"},{"key":"2613_CR51","doi-asserted-by":"publisher","first-page":"1377374","DOI":"10.3389\/fimmu.2024.1377374","volume":"15","author":"J Ma","year":"2024","unstructured":"Ma J, Gong T, Luo T, Li S, Zhong L, Zhao X, Mei C, Bu H, Jia Z, Kuang X, et al. Exacerbated lung inflammation in offspring with high maternal antibody levels following secondary RSV exposure. Front Immunol. 2024;15:1377374.","journal-title":"Front Immunol"},{"key":"2613_CR52","doi-asserted-by":"publisher","first-page":"1200195","DOI":"10.3389\/fimmu.2023.1200195","volume":"14","author":"A Sarker","year":"2023","unstructured":"Sarker A, Dhama N, Gupta RD. Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement. Front Immunol. 2023;14:1200195.","journal-title":"Front Immunol"},{"key":"2613_CR53","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s42003-022-03207-0","volume":"5","author":"S Wang","year":"2022","unstructured":"Wang S, Wang J, Yu X, Jiang W, Chen S, Wang R, Wang M, Jiao S, Yang Y, Wang W, et al. Antibody-dependent enhancement (ADE) of SARS-CoV-2 pseudoviral infection requires Fc\u03b3RIIB and virus-antibody complex with bivalent interaction. Commun Biol. 2022;5:262.","journal-title":"Commun Biol"},{"key":"2613_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29628","volume":"96","author":"S Thomas","year":"2024","unstructured":"Thomas S, Smatti MK, Alsulaiti H, Zedan HT, Eid AH, Hssain AA, Abu Raddad LJ, Gentilcore G, Ouhtit A, Althani AA, et al. Antibody-dependent enhancement (ADE) of SARS-CoV-2 in patients exposed to MERS-CoV and SARS-CoV-2 antigens. J Med Virol. 2024;96: e29628.","journal-title":"J Med Virol"},{"key":"2613_CR55","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41577-020-00410-0","volume":"20","author":"S Bournazos","year":"2020","unstructured":"Bournazos S, Gupta A, Ravetch JV. The role of IgG Fc receptors in antibody-dependent enhancement. Nat Rev Immunol. 2020;20:633\u201343.","journal-title":"Nat Rev Immunol"},{"key":"2613_CR56","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/BF01321121","volume":"122","author":"JS Yao","year":"1992","unstructured":"Yao JS, Kariwa H, Takashima I, Yoshimatsu K, Arikawa J, Hashimoto N. Antibody-dependent enhancement of hantavirus infection in macrophage cell lines. Arch Virol. 1992;122:107\u201318.","journal-title":"Arch Virol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02613-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-024-02613-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02613-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T07:23:38Z","timestamp":1738999418000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-024-02613-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2613"],"URL":"https:\/\/doi.org\/10.1186\/s12985-024-02613-6","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,8]]},"assertion":[{"value":"17 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Medical Ethics Committee of Shaanxi Provincial Center for Disease Control and Prevention (NO.1 in 2014) and informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}